However, its future guidance fell short of market expectations, leading to a decline in its stock price after the announcement. Separately, with uncertainty surrounding the company, see What’s Next ...
Below is Validea's guru fundamental report for WEST PHARMACEUTICAL SERVICES INC (WST). Of the 22 guru strategies we follow, WST rates highest using our P/B Growth Investor model based on the ...
1 Day WST -0.42% DJIA 0.37% S&P 500 -0.47% Health Care/Life Sciences -0.32% ...
Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the ...
West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...
West Pharmaceutical Services, Inc. WST delivered adjusted earnings per share (EPS) of $1.82 in the fourth quarter of 2024, down by a penny year over year. The figure topped the Zacks Consensus ...
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback